Literature DB >> 23151747

Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli.

Ira Palmer1, Paul T Wingfield.   

Abstract

High-level expression of many recombinant proteins in Escherichia coli leads to the formation of highly aggregated protein commonly referred to as inclusion bodies. Inclusion bodies are normally formed in the cytoplasm; however, if a secretion vector is used, they can form in the periplasmic space. Inclusion bodies can be recovered from cell lysates by low-speed centrifugation. Following pre-extaction (or washing), protein is extracted from washed pellets using guanidineHCl. The solubilized and unfolded protein is either directly folded or further purified by gel filtration in the presence of guanidineHCl as described in this unit. A support protocol describes the removal of guanidineHCl from column fractions so they can be monitored by SDS-PAGE.
© 2012 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151747      PMCID: PMC3809847          DOI: 10.1002/0471140864.ps0603s70

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  35 in total

1.  An efficient procedure to dialyze volumes in the range of 10-200 microliters.

Authors:  P Falson
Journal:  Biotechniques       Date:  1992-07       Impact factor: 1.993

Review 2.  Protein folding and protein refolding.

Authors:  R Seckler; R Jaenicke
Journal:  FASEB J       Date:  1992-05       Impact factor: 5.191

3.  Folding proteins.

Authors:  N J Darby; T E Creighton
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

Review 4.  The denaturation and degradation of stable enzymes at high temperatures.

Authors:  R M Daniel; M Dines; H H Petach
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  Why does ribonuclease irreversibly inactivate at high temperatures?

Authors:  S E Zale; A M Klibanov
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

6.  A comparison of the effectiveness of protein denaturants for beta-lactoglobulin and ribonuclease.

Authors:  C N Pace; H F Marshall
Journal:  Arch Biochem Biophys       Date:  1980-01       Impact factor: 4.013

7.  Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli.

Authors:  G O Daumy; J M Merenda; A S McColl; G C Andrews; A E Franke; K F Geoghegan; I G Otterness
Journal:  Biochim Biophys Acta       Date:  1989-09-14

8.  Protein denaturation with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions of electrostatic interactions.

Authors:  O D Monera; C M Kay; R S Hodges
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

9.  Selective precipitation of proteins from guanidine hydrochloride-containing solutions with ethanol.

Authors:  R B Pepinsky
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

10.  Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR.

Authors:  K Oberg; B A Chrunyk; R Wetzel; A L Fink
Journal:  Biochemistry       Date:  1994-03-08       Impact factor: 3.162

View more
  18 in total

1.  Characterization of chloroplast protein import without Tic56, a component of the 1-megadalton translocon at the inner envelope membrane of chloroplasts.

Authors:  Daniel Köhler; Cyril Montandon; Gerd Hause; Petra Majovsky; Felix Kessler; Sacha Baginsky; Birgit Agne
Journal:  Plant Physiol       Date:  2015-03       Impact factor: 8.340

2.  Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.

Authors:  Sarah L Keasey; Christine L Pugh; Stig M R Jensen; Jessica L Smith; Robert D Hontz; Anna P Durbin; Dawn M Dudley; David H O'Connor; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

3.  Methods for Determining the Cellular Functions of Vimentin Intermediate Filaments.

Authors:  Karen M Ridge; Dale Shumaker; Amélie Robert; Caroline Hookway; Vladimir I Gelfand; Paul A Janmey; Jason Lowery; Ming Guo; David A Weitz; Edward Kuczmarski; Robert D Goldman
Journal:  Methods Enzymol       Date:  2015-12-19       Impact factor: 1.600

4.  Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.

Authors:  Magdalena Korecka; Teresa Waligorska; Michal Figurski; Jon B Toledo; Steven E Arnold; Murray Grossman; John Q Trojanowski; Leslie M Shaw
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Involvement of PG2212 zinc finger protein in the regulation of oxidative stress resistance in Porphyromonas gingivalis W83.

Authors:  Yuetan Dou; Wilson Aruni; Tianlong Luo; Francis Roy; Charles Wang; Hansel M Fletcher
Journal:  J Bacteriol       Date:  2014-09-15       Impact factor: 3.490

6.  Enhancement of Solubility, Purification, and Inclusion Body Refolding of Active Human Mitochondrial Aldehyde Dehydrogenase 2.

Authors:  Tingting Zhao; Hui Huang; Peizhu Tan; Yanze Li; Xiuchen Xuan; Fenglan Li; Yuchen Zhao; Yuwei Cao; Zhaojing Wu; Yu Jiang; Yuanyuan Zhao; Aimiao Yu; Kuo Wang; Jiaran Xu; Lingyun Zhou; Dan Yang
Journal:  ACS Omega       Date:  2021-04-28

7.  At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization.

Authors:  Julian Ebner; Diana Humer; Robert Klausser; Viktor Rubus; Reinhard Pell; Oliver Spadiut; Julian Kopp
Journal:  Bioengineering (Basel)       Date:  2021-06-07

Review 8.  Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies.

Authors:  Yin Yin Siew; Wei Zhang
Journal:  Bioresour Bioprocess       Date:  2021-07-27

9.  Controlled localization of functionally active proteins to inclusion bodies using leucine zippers.

Authors:  Su-Lim Choi; Sang Jun Lee; Soo-Jin Yeom; Hyun Ju Kim; Young Ha Rhee; Heung-Chae Jung; Seung-Goo Lee
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

10.  Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice.

Authors:  Nahid Mehri; Abbas Jamshidizad; Zahra Ghanei; Ali-Asghar Karkhane; Mehdi Shamsara
Journal:  Mol Biotechnol       Date:  2021-07-16       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.